Chantal Hargreaves (@chantalh88) 's Twitter Profile
Chantal Hargreaves

@chantalh88

Scientist. Thereโ€™s no e.

ID: 1134814103640399874

calendar_today01-06-2019 13:29:00

319 Tweet

185 Takipรงi

783 Takip Edilen

๐š‚๐šŠ๐š›๐šŠ๐š‘ ๐š‚๐šŠ๐šœ๐šœ๐š˜๐š— (@sarah_sasson) 's Twitter Profile Photo

Just published! "Identification of neutralising pembrolizumab anti-drug antibodies (ADAs) in patients with melanoma" Scientific Reports . We found the rate of neutralising ADAs (7%) was higher in our real world cohort than has been previously reported. 1/2 rdcu.be/cyATX

Just published! "Identification of neutralising pembrolizumab anti-drug antibodies (ADAs) in patients with melanoma" <a href="/SciReports/">Scientific Reports</a> .  We found the rate of neutralising ADAs (7%) was higher in our real world cohort than has been previously reported. 1/2
rdcu.be/cyATX
Nucleome Therapeutics (@nucleometx) 's Twitter Profile Photo

We are excited to be featured in Nature Biotechnology which has highlighted our novel technique, Micro-Capture-C (MMC), which maps the #3Dgenome with a super-fine resolution. Please read the full article: go.nature.com/3aoIPmm #darkgenome #genomics #drugdiscovery

Chantal Hargreaves (@chantalh88) 's Twitter Profile Photo

Are any other immunologists getting messages on LinkedIn from supposedly vaccine hesitant people claiming theyโ€™re definitely not anti-vaxx and just want โ€œan expert viewโ€ then spouting conspiracy theories? Do you block/engage/ignore?

Ed Hollox (@edhollox) 's Twitter Profile Photo

A common human inversion that carries risk alleles for lots of traits? What's going on? From the UK or a low/middle income countries? Study with me and Louise V Wain with a Wellcome funded PhD at University of Leicester. AfricanSocHumGenet ASHG The Genetics Society #ASHG2021 Please RT!

NHS Oxfordshire (@nhs_oxon) 's Twitter Profile Photo

โš ๏ธ As of today Oxfordshire, Buckinghamshire and Berkshire are all offering walk-in COVID-19 boosters alongside booked appointments, to eligible people. The Kassam stadium is now accepting Pfizer booster walk ins accepted between 3 and 7pm! oxfordshireccg.nhs.uk/news/mass-vaccโ€ฆ

โš ๏ธ As of today Oxfordshire, Buckinghamshire and Berkshire are all offering walk-in COVID-19 boosters alongside booked appointments, to eligible people. 

The Kassam stadium is now accepting Pfizer booster walk ins accepted between 3 and 7pm! 

oxfordshireccg.nhs.uk/news/mass-vaccโ€ฆ
NDMPapers (@ndm_papers) 's Twitter Profile Photo

Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants dlvr.it/SFgJXv

Chantal Hargreaves (@chantalh88) 's Twitter Profile Photo

Any advice from clinical immunology or translational researchers on preprints? medRxiv wonโ€™t accept the level of clinical detail expected/accepted by specialty journals. Other options? (Patient permission to publish) #preprint #clinicalimmunology #immunodeficiency

Cllr Anna Railton ๐ŸŒน is on ๐Ÿฆ‹ (@rail_guns) 's Twitter Profile Photo

Yesterday someone lost their life on the Plain, a roundabout every cyclist in Oxford knows is complete bullshit. The first of these images shows a classic "guess I'll just die then" cycle lane and the second is crash data from bikedata.cyclestreets.net/collisions:fieโ€ฆ Speaks for itself (2/5)

Yesterday someone lost their life on the Plain, a roundabout every cyclist in Oxford knows is complete bullshit. 
The first of these images shows a classic "guess I'll just die then" cycle lane and the second is crash data from bikedata.cyclestreets.net/collisions:fieโ€ฆ Speaks for itself (2/5)
Dr Lucy Garner (@thelucygarner) 's Twitter Profile Photo

Two years after completing my PhD and lots of COVID-19 research in between, my #MAITcell study is up on bioRxiv biorxiv.org/content/10.110โ€ฆ. This work is very special to me - hope you enjoy!

Nucleome Therapeutics (@nucleometx) 's Twitter Profile Photo

We are thrilled to announce that we have raised ยฃ37.5 million in an oversubscribed Series A financing. The funds will be used to advance our autoimmune disease programmes, fuel expansion of our dark genome atlas and further develop our pioneering platform. nucleome.com/news-publicatiโ€ฆ

We are thrilled to announce that we have raised ยฃ37.5 million in an oversubscribed Series A financing. The funds will be used to advance our autoimmune disease programmes, fuel expansion of our dark genome atlas and further develop our pioneering platform. nucleome.com/news-publicatiโ€ฆ